,X,FilingDate,TradeDate,Ticker,InsiderName,Title,TradeType,Price,Qty,Owned,delta_Own,Value,1d,1w,1m,6m,ticker
0,,2021-09-22 21:30:44,2021-09-22,HARP,Erbez Georgia,CFO,P - Purchase,8.1,10300,98207,+12%,83430.0,,,,,HARP
1,,2021-08-12 16:15:15,2021-01-11,HARP,"New Leaf Ventures Iii, L.P.",10%,P - Purchase,17.0,235294,3156699,+8%,3999998.0,,,,,HARP
2,,2021-08-12 16:15:00,2021-01-11,HARP,Hunt Ronald,"Dir, 10%",P - Purchase,17.0,235294,3156699,+8%,3999998.0,,,,,HARP
3,D,2021-07-06 18:01:43,2021-07-01,HARP,Wesche Holger,Chief Scientific Officer,M - OptEx,0.6,10000,52852,+23%,6000.0,,,,,HARP
4,D,2021-07-06 18:01:43,2021-07-01,HARP,Wesche Holger,Chief Scientific Officer,S - Sale+OE,14.0,-10000,52852,-16%,-140000.0,,,,,HARP
5,M,2021-06-02 18:09:39,2021-05-28,HARP,Gadicke Ansbert,10%,S - Sale,20.63,-57494,6328095,-1%,-1186190.0,,,,,HARP
6,M,2021-05-27 19:40:41,2021-05-26,HARP,Gadicke Ansbert,10%,S - Sale,20.22,-17159,6385589,0%,-346938.0,,,,,HARP
7,M,2021-05-24 20:11:52,2021-05-21,HARP,Gadicke Ansbert,10%,S - Sale,20.18,-15907,6402748,0%,-321030.0,,,,,HARP
8,M,2021-05-20 19:20:37,2021-05-18,HARP,Gadicke Ansbert,10%,S - Sale,20.49,-47948,6418655,-1%,-982227.0,,,,,HARP
9,M,2021-05-17 17:23:41,2021-05-13,HARP,Gadicke Ansbert,10%,S - Sale,20.05,-16421,6466603,0%,-329314.0,,,,,HARP
10,M,2021-05-12 18:09:04,2021-05-10,HARP,Gadicke Ansbert,10%,S - Sale,21.04,-68262,6483024,-1%,-1436556.0,,,,,HARP
11,,2021-05-06 16:05:43,2021-05-05,HARP,Gadicke Ansbert,10%,S - Sale,22.52,-10172,6551286,0%,-229107.0,,,,,HARP
12,M,2021-05-04 17:43:55,2021-04-30,HARP,Gadicke Ansbert,10%,S - Sale,22.48,-328519,6561458,-5%,-7386435.0,,,,,HARP
13,M,2021-04-29 17:46:23,2021-04-27,HARP,Gadicke Ansbert,10%,S - Sale,21.99,-130143,6889977,-2%,-2861368.0,,,,,HARP
14,,2021-04-22 16:04:14,2021-04-21,HARP,Gadicke Ansbert,10%,S - Sale,18.97,-8972,7020120,0%,-170229.0,,,,,HARP
15,M,2021-04-20 18:07:10,2021-04-16,HARP,Gadicke Ansbert,10%,S - Sale,19.04,-38152,7029092,-1%,-726550.0,,,,,HARP
16,M,2021-04-15 20:01:16,2021-04-13,HARP,"Mpm Bioventures 2014, L.P.",Former 10% Owner,S - Sale,20.16,-4666,3220844,0%,-94075.0,,,,,HARP
17,M,2021-04-15 20:00:20,2021-04-13,HARP,Gadicke Ansbert,10%,S - Sale,20.16,-38556,7067244,-1%,-777359.0,,,,,HARP
18,M,2021-04-13 16:13:25,2021-04-09,HARP,Gadicke Ansbert,10%,S - Sale,21.9,-30928,7105800,0%,-677357.0,,,,,HARP
19,M,2021-04-13 16:12:06,2021-04-09,HARP,"Mpm Bioventures 2014, L.P.",10%,S - Sale,23.15,-12796,3225510,0%,-296261.0,,,,,HARP
20,D,2021-04-05 17:00:53,2021-04-01,HARP,Wesche Holger,Chief Scientific Officer,M - OptEx,0.6,10000,52852,+23%,6000.0,,,,,HARP
21,D,2021-04-05 17:00:53,2021-04-01,HARP,Wesche Holger,Chief Scientific Officer,S - Sale+OE,20.45,-10000,52852,-16%,-204491.0,,,,,HARP
22,D,2021-02-18 08:31:30,2021-02-17,HARP,Erbez Georgia,CFO,M - OptEx,2.12,25000,87907,+40%,53000.0,,,,,HARP
23,,2021-02-12 17:03:24,2021-02-10,HARP,"Mpm Bioventures 2014, L.P.",10%,S - Sale,20.0,-183051,7136728,-3%,-3661020.0,,,,,HARP
24,M,2021-02-09 18:14:02,2021-02-05,HARP,"Mpm Bioventures 2014, L.P.",10%,S - Sale,20.06,-91700,7319779,-1%,-1839337.0,,,,,HARP
25,M,2021-02-04 19:30:05,2021-02-02,HARP,"Mpm Bioventures 2014, L.P.",10%,S - Sale,20.22,-120073,7411479,-2%,-2427558.0,,,,,HARP
26,M,2021-01-27 20:35:22,2021-01-25,HARP,"Mpm Bioventures 2014, L.P.",10%,S - Sale,20.02,-721194,7531552,-9%,-14441349.0,,,,,HARP
27,M,2021-01-22 20:16:40,2021-01-20,HARP,"Mpm Bioventures 2014, L.P.",10%,S - Sale,22.51,-68455,8252746,-1%,-1540761.0,,,,,HARP
28,D,2021-01-06 18:25:56,2021-01-04,HARP,Wesche Holger,Chief Scientific Officer,M - OptEx,0.6,10000,52852,+23%,6000.0,,,,,HARP
29,D,2021-01-06 18:25:56,2021-01-04,HARP,Wesche Holger,Chief Scientific Officer,S - Sale+OE,18.38,-10000,52852,-16%,-183837.0,,,,,HARP
30,D,2020-10-05 16:25:59,2020-10-01,HARP,Wesche Holger,Chief Scientific Officer,M - OptEx,0.6,10000,52669,+23%,6000.0,,,,,HARP
31,D,2020-10-05 16:25:59,2020-10-01,HARP,Wesche Holger,Chief Scientific Officer,S - Sale+OE,16.27,-10000,52669,-16%,-162737.0,,,,,HARP
32,M,2020-08-20 18:36:55,2020-08-18,HARP,Erbez Georgia,CFO,P - Purchase,11.46,7098,62907,+13%,81337.0,,,,,HARP
33,,2020-08-04 08:32:22,2020-07-31,HARP,Erbez Georgia,CFO,P - Purchase,10.92,1817,55809,+3%,19842.0,,,,,HARP
34,D,2020-07-02 19:18:17,2020-07-01,HARP,Wesche Holger,Chief Scientific Officer,M - OptEx,0.6,10000,52669,+23%,6000.0,,,,,HARP
35,D,2020-07-02 19:18:17,2020-07-01,HARP,Wesche Holger,Chief Scientific Officer,S - Sale+OE,16.2,-10000,52669,-16%,-161989.0,,,,,HARP
36,M,2020-05-29 16:32:05,2020-05-27,HARP,Arix Bioscience Plc,10%,S - Sale,21.37,-378655,2193704,-15%,-8091070.0,,,,,HARP
37,D,2020-05-20 18:34:30,2020-05-18,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,1522,45754,+3%,3227.0,,,,,HARP
38,D,2020-05-20 18:34:30,2020-05-18,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,14.77,-1522,45754,-3%,-22479.0,,,,,HARP
39,D,2020-05-13 20:45:18,2020-05-12,HARP,Wesche Holger,Chief Scientific Officer,M - OptEx,0.6,1400,52669,+3%,840.0,,,,,HARP
40,D,2020-05-13 20:45:18,2020-05-12,HARP,Wesche Holger,Chief Scientific Officer,S - Sale+OE,14.09,-1400,52669,-3%,-19720.0,,,,,HARP
41,DM,2020-05-11 21:37:09,2020-05-07,HARP,Wesche Holger,Chief Scientific Officer,M - OptEx,0.6,7350,52669,+16%,4410.0,,,,,HARP
42,DM,2020-05-11 21:37:09,2020-05-07,HARP,Wesche Holger,Chief Scientific Officer,S - Sale+OE,14.1,-7350,52669,-12%,-103641.0,,,,,HARP
43,D,2020-05-05 16:35:04,2020-05-01,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,5826,45754,+15%,12351.0,,,,,HARP
44,D,2020-05-05 16:35:04,2020-05-01,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,12.07,-5826,45754,-11%,-70301.0,,,,,HARP
45,D,2020-04-30 16:58:03,2020-04-28,HARP,Wesche Holger,Chief Scientific Officer,M - OptEx,0.6,1250,52669,+2%,750.0,,,,,HARP
46,D,2020-04-30 16:58:03,2020-04-28,HARP,Wesche Holger,Chief Scientific Officer,S - Sale+OE,14.05,-1250,52669,-2%,-17565.0,,,,,HARP
47,DM,2020-04-17 19:10:43,2020-04-16,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,1521,45754,+3%,3225.0,,,,,HARP
48,DM,2020-04-17 19:10:43,2020-04-16,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,12.05,-1521,45754,-3%,-18330.0,,,,,HARP
49,D,2020-04-15 16:48:43,2020-04-13,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,4556,45754,+11%,9659.0,,,,,HARP
50,D,2020-04-15 16:48:43,2020-04-13,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,12.06,-4556,45754,-9%,-54959.0,,,,,HARP
51,DM,2020-04-08 18:10:11,2020-04-06,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,1270,45754,+3%,2692.0,,,,,HARP
52,DM,2020-04-08 18:10:11,2020-04-06,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,12.0,-1270,45754,-3%,-15241.0,,,,,HARP
53,DM,2020-03-18 17:28:17,2020-03-16,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,1521,45754,+3%,3225.0,,,,,HARP
54,DM,2020-03-18 17:28:17,2020-03-16,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,12.0,-1521,45754,-3%,-18252.0,,,,,HARP
55,D,2020-03-03 21:31:57,2020-03-02,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,5826,45754,+15%,12351.0,,,,,HARP
56,D,2020-03-03 21:31:57,2020-03-02,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,14.68,-5826,45754,-11%,-85526.0,,,,,HARP
57,D,2020-02-20 17:11:35,2020-02-18,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,1521,45754,+3%,3225.0,,,,,HARP
58,D,2020-02-20 17:11:35,2020-02-18,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,15.0,-1521,45754,-3%,-22815.0,,,,,HARP
59,D,2020-02-04 20:11:58,2020-02-03,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,5826,45754,+15%,12351.0,,,,,HARP
60,D,2020-02-04 20:11:58,2020-02-03,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,13.9,-5826,45754,-11%,-81006.0,,,,,HARP
61,,2020-01-23 08:34:08,2020-01-21,HARP,Erbez Georgia,CFO,P - Purchase,14.09,6700,53992,+14%,94418.0,,,,,HARP
62,D,2020-01-21 20:05:05,2020-01-16,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,1521,45754,+3%,3225.0,,,,,HARP
63,D,2020-01-21 20:05:05,2020-01-16,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,14.94,-1521,45754,-3%,-22725.0,,,,,HARP
64,D,2020-01-06 21:55:51,2020-01-02,HARP,Wesche Holger,Chief Scientific Officer,M - OptEx,0.6,10000,52669,+23%,6000.0,,,,,HARP
65,D,2020-01-06 21:55:51,2020-01-02,HARP,Wesche Holger,Chief Scientific Officer,S - Sale+OE,14.4,-10000,52669,-16%,-143987.0,,,,,HARP
66,D,2020-01-06 21:46:43,2020-01-02,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,5826,45754,+15%,12351.0,,,,,HARP
67,D,2020-01-06 21:46:43,2020-01-02,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,14.18,-5826,45754,-11%,-82600.0,,,,,HARP
68,,2019-12-30 17:32:07,2019-12-27,HARP,Baeuerle Patrick,Dir,S - Sale,15.98,-87379,262136,-25%,-1396281.0,,,,,HARP
69,D,2019-12-18 16:14:30,2019-12-16,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,1521,45754,+3%,3225.0,,,,,HARP
70,D,2019-12-18 16:14:30,2019-12-16,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,17.02,-1521,45754,-3%,-25888.0,,,,,HARP
71,M,2019-12-17 21:23:21,2019-12-13,HARP,Chin Mark,"Dir, 10%",S - Sale,17.01,-36558,2572359,-1%,-621990.0,,,,,HARP
72,M,2019-12-17 19:20:01,2019-12-13,HARP,Arix Bioscience Plc,10%,S - Sale,17.01,-36558,2572359,-1%,-621990.0,,,,,HARP
73,M,2019-12-10 20:07:22,2019-12-06,HARP,Chin Mark,"Dir, 10%",S - Sale,17.75,-283202,2608917,-10%,-5025686.0,,,,,HARP
74,M,2019-12-10 19:27:22,2019-12-06,HARP,Arix Bioscience Plc,10%,S - Sale,17.75,-283202,2608917,-10%,-5025686.0,,,,,HARP
75,D,2019-12-06 16:41:41,2019-12-04,HARP,Erbez Georgia,CFO,M - OptEx,2.12,47292,47292,New,100259.0,,,,,HARP
76,D,2019-12-04 16:42:13,2019-12-02,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,5826,45754,+15%,12351.0,,,,,HARP
77,D,2019-12-04 16:42:13,2019-12-02,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,17.98,-5826,45754,-11%,-104751.0,,,,,HARP
78,D,2019-11-19 16:24:26,2019-11-18,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,18252,45754,+66%,38694.0,,,,,HARP
79,D,2019-11-19 16:24:26,2019-11-18,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,13.37,-18252,45754,-29%,-243964.0,,,,,HARP
80,D,2019-11-05 16:09:31,2019-11-01,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,5826,45754,+15%,12351.0,,,,,HARP
81,D,2019-11-05 16:09:31,2019-11-01,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,13.17,-5826,45754,-11%,-76702.0,,,,,HARP
82,DM,2019-10-16 17:14:36,2019-10-14,HARP,Sacks Natalie,Chief Medical Officer,M - OptEx,2.12,24150,45754,+112%,51198.0,,,,,HARP
83,DM,2019-10-16 17:14:36,2019-10-14,HARP,Sacks Natalie,Chief Medical Officer,S - Sale+OE,13.24,-24150,45754,-35%,-319762.0,,,,,HARP
84,D,2019-09-06 19:17:00,2019-06-05,HARP,McMahon Gerald Phd,"Pres, CEO",M - OptEx,0.6,169462,172462,>999%,101677.0,,,,,HARP
85,,2019-05-16 08:32:03,2019-05-14,HARP,McMahon Gerald Phd,"Pres, CEO",P - Purchase,10.16,1000,3000,+50%,10157.0,,,,,HARP
86,,2019-05-10 08:31:16,2019-05-08,HARP,McMahon Gerald Phd,"Pres, CEO",P - Purchase,10.56,1000,2000,+100%,10559.0,,,,,HARP
87,,2019-05-07 16:12:38,2019-05-03,HARP,McMahon Gerald Phd,"Pres, CEO",P - Purchase,10.53,1000,1000,New,10530.0,,,,,HARP
88,D,2019-02-14 18:01:24,2019-02-12,HARP,Arix Bioscience Plc,10%,C - Converted deriv,0.0,2463548,2892119,-46%,0.0,,,,,HARP
89,D,2019-02-14 18:01:24,2019-02-12,HARP,Arix Bioscience Plc,10%,P - Purchase,14.0,428571,2892119,+17%,5999994.0,,,,,HARP
90,D,2019-02-14 17:34:03,2019-02-12,HARP,Ubs Oncology Impact Fund L.P.,10%,C - Converted deriv,0.0,3521773,3898422,-47%,0.0,,,,,HARP
91,D,2019-02-14 17:34:03,2019-02-12,HARP,Ubs Oncology Impact Fund L.P.,10%,P - Purchase,14.0,250000,3898422,+7%,3500000.0,,,,,HARP
92,D,2019-02-14 17:34:03,2019-02-12,HARP,Ubs Oncology Impact Fund L.P.,10%,S - Sale+OE,14.0,-447,3898422,0%,-6258.0,,,,,HARP
93,D,2019-02-14 17:34:03,2019-02-12,HARP,Ubs Oncology Impact Fund L.P.,10%,X - OptEx,0.05,127096,3898422,-3%,6253.0,,,,,HARP
94,D,2019-02-14 17:33:22,2019-02-12,HARP,"New Leaf Ventures Iii, L.P.",10%,C - Converted deriv,0.0,2492834,678566,-79%,0.0,,,,,HARP
95,D,2019-02-14 17:33:22,2019-02-12,HARP,"New Leaf Ventures Iii, L.P.",10%,P - Purchase,14.0,428571,678566,+171%,5999994.0,,,,,HARP
96,D,2019-02-14 17:32:09,2019-02-12,HARP,"Mpm Bioventures 2014, L.P.",10%,C - Converted deriv,0.0,3521767,4524425,-44%,0.0,,,,,HARP
97,D,2019-02-14 17:32:09,2019-02-12,HARP,"Mpm Bioventures 2014, L.P.",10%,P - Purchase,14.0,250000,4524425,+6%,3500000.0,,,,,HARP
98,D,2019-02-14 17:32:09,2019-02-12,HARP,"Mpm Bioventures 2014, L.P.",10%,S - Sale+OE,14.0,-1524,4524425,0%,-21336.0,,,,,HARP
99,D,2019-02-14 17:32:09,2019-02-12,HARP,"Mpm Bioventures 2014, L.P.",10%,X - OptEx,0.05,432119,4524425,-9%,21260.0,,,,,HARP
100,D,2019-02-14 17:30:01,2019-02-12,HARP,Hunt Ronald,"Dir, 10%",C - Converted deriv,0.0,2492834,678566,-79%,0.0,,,,,HARP
101,D,2019-02-14 17:30:01,2019-02-12,HARP,Hunt Ronald,"Dir, 10%",P - Purchase,14.0,428571,678566,+171%,5999994.0,,,,,HARP
